APPLICATIONS PUBLISHED 22 SEPTEMBER 2004
Published: 1-Apr-2005
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Stable surfactant compsns for suspending components
Rhodia 1458337*
Compsn comprising at least an alkanolamide for inhibiting langerhans cell migration, and uses thereof
Laboratoires Expanscience 1458347*
Cosmetic compsn comprising a fatty acid material and preparation method therefor
Unilever 1458348*
Compsn comprising at least an oxazolin for inhibiting langerhans cell migration, and uses thereof
Laboratoires Expanscience 1458349*
Talc-containing cosmetic cleansing emulsion
Beiersdorf 1458350*
Solid dose micro implant
Novo Nordisk 1458352*
Formulation dosage form for the controlled delivery of therapeutic agents
Alza Corp 1458353*
Medicinal aerosol formulations comprising ion pair complexes
3M Innovative Properties Company 1458354*
Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
Guilford Pharmaceuticals 1458355*
Micronised pharmaceutical or nutraceutical powder with immediate release
Besins International Belgique 1458356*
Medicinal aerosol compsns with a functionalised polyethyleneglycol excipient
3M Innovative Properties Company 1458357*
Stable topical formulation of clarithromycin
Ranbaxy Laboratories 1458358*
Microemulsion preconcentrate
CJ Corporation 1458359*
Pulmonary delivery of aminoglycosides
Nektar Therapeutics 1458360*
Compounds for sustained action product delivery
Advanced Inhalation Research 1458361*
Pharmaceutical compsns in particulate form
Becton, Dickinson & Company 1448362*
Pre-formulation for the tableting of natural mixtures of conjugated oestrogens
Solvay Pharmaceuticals 1458363*
Pharmaceutical compsns comprising metformine and glibenclamide for the treatment of type II diabetes mellitus
Menarini International Operations Luxembourg 1458364*
Improved polymer-lipid delivery vehicles
Celator Technologies 1458365*
Adhesive transdermal formulations of diclofenac sodium
Fidia Farmaceutici; APR Applied Pharma Research 1458366*
Uniform films for rapid dissolve dosage form incorporating taste-masking compsns
Kosmos Pharma 1458367*
Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure
Eli Lilly 1458368*
Gel comprising at least a retinoid and benzoyl peroxide
Galderama Research & Development 1458369*
Treatment of faecal incontinence and other conditions with 1R,2S-methoxamine
Norgine Europe BV 1458370*
Pyruvate cardioplegia solutions for administration to the heart during cardiopulmonary surgery and methods of use thereof
Mallet, Robert 1458371*
Calcium L-threonate for preventing or treating cartilage related diseases
Juneng Industry 1458372*
Use of lipoxin analogues to promote cell defence against gram-negative infections
The Brigham & Women's Hospital 1458373*
Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
Novo Nordisk 1458374*
Compsns for decreasing activity of hormone-sensitive lipase
Novo Nordisk 1458375*
Darifenacin for use in the treatment of urgency induced by overactive bladder
Novartis International Pharmaceuticals 1458376*
5HT4 partial agonist pharmaceutical compsns
Novartis 1458377*
Amino acid derivatives useful for the treatment of Alzheimer's disease
Elan Pharmaceuticals; Pharmacia & Upjohn 1458378*
Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compsns containing them
Pharmacia Italia 1458379*
Cis-2,4,5-triphenyl-imidazoles and their use in the treatment of tumours
F Hoffmann-La Roche 1458380*
Triazoles as oxytocin antagonists
Applied Research Systems 1458381*
Amide derivatives as GK activators
Novo Nordisk 1458382*
Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
Merck 1458383*
Amlopidine bezylate tablets with improved stability
Egis Gyogyszergyar 1458384*
Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
Merck 1458385*
Aroyl pyrrazole heteroeryl and methanols useful for treating a central nervous system disorder
Ortho-McNeil Pharmaceutical 1458386*
Orodispersible tablets containing fexofenadine
Ethypharm 1458387*
A liquid pharmaceutical formulation comprising nicotine for the administration to the oral cavity
Pfizer Health 1458388*
Use of moxaverin for treating erectile dysfunction, forms of dementia or diseases associated to an arteriosclerotic occlusion
Molecular and Drug Research 1458389*
A method of treating bacterial infections using gemifloxacin or a salt thereof and a carbapenem antibacterial agent
LG Life Sciences 1458390*
A method of treating bacterial infections using gemifloxacin or a salt thereof and a beta-lactam antibiotic
LG Life-Sciences 1458391*
Inhibitors of IMPDH enzyme
Bristol-Myers Squibb 1458392*
Substituted diketopiperazines as oxytocin antagonists
Glaxo Group 1458393*
Use of oxindole derivatives in the treatment of dementia related diseases, Alzheimer's disease and conditions associated with glycogen synthase kinase-3
AstraZeneca 1458394*
New use
AstraZeneca 1458395*
4-arylquinazolines and use thereof as NHE-3 inhibitors
Merck Patent 1458396*
Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
Duke University 1458397*
Antibiotic formulation and a method of making this formulation
Phoenix Scientific 1458398*
Pregnane steroids for use in the treatment of CNS disorders
Umecrine 1458399*
Liquid bisphosphonate formulations for bone disorders
Merck 1458400*
Compsn comprising dextrinsulfate for the treatment of sexually transmitted diseases
ML Laboratories 1458401*
Improvements of or relating to liquid, eye-installable preparations comprising sodium hyaluronate
Renaissance Healthcare (Europe) 1458402*
Compsns and methods for the treatment and clinical remission of psoriasis
Akiva LLC 1458403*
Polyphenol inhibition of nucleoside diphosphate kinase-B activity and cancer metastasis
Research Development Foundation 1458404*
Use of FK506 and analogues for treating allergic diseases
Sucampo 1458405*
A method of treatment and agents useful for the same
The Corporation of the Trustees of the Orders of the Sisters of Mercy in Queensland 1458406*
Liquid compsns of modified factor VII polypeptides
Novo Nordisk 1458407*
Liquid compsn of factor VII polypeptides
Novo Nordisk Health Care 1458408*
14081, a human trypsin-like serine protease family member and uses therefor
Millennium Pharmaceuticals 1458409*
Stabilised MRNA tumour vaccine
Curevac 1458410*
